Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. Its products include CaverStem, FemCelz, StemSpine and ImmCelz. The company was founded by Timothy Warbington on December 3, 1998 and is headquartered in Phoenix, AZ.
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Creative Medical Technology Holdings Inc market cap is $3.34M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Creative Medical Technology Holdings Inc 52 week high is $4.72 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Creative Medical Technology Holdings Inc 52 week low is $0.44 as of November 21, 2026.
Creative Medical Technology Holdings Inc stock price today is $0.4025.
Creative Medical Technology Holdings Inc stock price yesterday was $0.44.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Creative Medical Technology Holdings Inc's P/E ratio is -0.26.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Creative Medical Technology Holdings Inc P/B ratio is 0.4807.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Creative Medical Technology Holdings Inc 50-day moving average is $0.7753.
Creative Medical Technology Holdings Inc has 4 employees.